Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
09/02/1993 | WO1993017041A1 Car receptors and related molecules and methods |
09/02/1993 | WO1993017030A1 Immunological detection of organophosphates |
09/02/1993 | WO1993016725A1 Early antigen for autoimmune diabetes |
09/02/1993 | WO1993016723A1 Purified vacuolating toxin from helicobacter pylori and methods to use same |
09/02/1993 | WO1993016722A1 Antigens protective against echinococcus granulosus infection and vaccines containing such antigens |
09/02/1993 | WO1993016709A1 Therapeutic domains of von willebrand factor |
09/02/1993 | CA2131028A1 Hepatitis c virus peptides |
09/02/1993 | CA2130997A1 Early antigen for autoimmune diabetes |
09/02/1993 | CA2117608A1 Endo-1,4-beta-d-glucanase |
09/02/1993 | CA2117491A1 Car receptors and related molecules and methods |
09/01/1993 | EP0558024A2 Novel vector having promoter that is inducible by methanol and/or glycerol |
09/01/1993 | EP0557966A1 Prostaglandin E receptors, their DNA and production |
09/01/1993 | EP0557954A2 A process for producing epsilon-poly-L-lysine |
09/01/1993 | EP0557897A1 Antigen binding proteins and methods for their production |
09/01/1993 | EP0557663A1 Assessment of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating under-carboxylated osteocalcin |
09/01/1993 | EP0557535A1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa |
09/01/1993 | EP0557455A1 Recombinant feline coronavirus s proteins |
09/01/1993 | EP0557451A1 Characterization of platelet aggregation disorders |
09/01/1993 | EP0557442A1 Antithrombosis agents |
09/01/1993 | EP0557418A1 A $g(b)-TYPE TRANSFORMING GROWTH FACTOR |
09/01/1993 | EP0557388A1 Diagnosis and treatment of multiple sclerosis |
09/01/1993 | EP0557300A1 Bispecific antibodies, method of production, and uses thereof |
09/01/1993 | EP0542929A4 Glycogen biosynthetic enzymes in plants |
09/01/1993 | EP0241539B1 Expression systems for overproduction of desired proteins |
09/01/1993 | CN1021973C Production of proteins in procaryotes |
08/31/1993 | US5241051 Secreted by human erythroblastoid cells |
08/31/1993 | US5241049 Neutrophil chemoattractants |
08/31/1993 | US5240911 Method of reducing blood sugar levels using a hypoglycemic agent |
08/31/1993 | US5240848 Cloning; genetic engineering |
08/31/1993 | US5240847 Cloned gene |
08/31/1993 | US5240846 Gene therapy vector for cystic fibrosis |
08/31/1993 | US5240834 Solubilization of protein after bacterial expression using sarkosyl |
08/31/1993 | US5240833 Method for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides |
08/31/1993 | US5240832 Culturing cells transformed with vectors to produce thyroid stimulating hormone |
08/31/1993 | CA1321766C Process for producing cell having high productivity of protein and process for preparing protein by using the cell |
08/31/1993 | CA1321765C Immunodiagnostic assays using chimeric antigens |
08/31/1993 | CA1321764C Dna sequence to target proteins to the mammary gland for efficient secretion |
08/31/1993 | CA1321763C Monoclonal antibody specific to human pancreatic phospholipase a |
08/29/1993 | CA2089966A1 Antigen binding proteins and methods for their production |
08/25/1993 | EP0557076A1 Selective removal of N-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1 |
08/25/1993 | EP0556496A2 Antibodies against tumor-associated mucin glycoprotein |
08/25/1993 | EP0556434A2 Process for economically producing a protein by using silkworms |
08/25/1993 | EP0556395A1 Novel cytokine |
08/25/1993 | EP0556345A1 Retroviral vectors useful for gene therapy. |
08/25/1993 | EP0556320A1 Monoclonal antibodies to hepatitis c virus and method for using same |
08/25/1993 | EP0556292A1 Hepatitis c virus asialoglycoproteins |
08/25/1993 | EP0556207A1 Modified human tnfalpha (tumor necrosis factor alpha) receptor |
08/25/1993 | EP0556182A1 Dna capable of site-specific integration into mycobacteria |
08/25/1993 | EP0556171A1 Growth hormone antagonists |
08/25/1993 | EP0555405A4 Specific detection of antibodies to human t-cell leukemia viruses |
08/25/1993 | EP0199801B1 Methods for protein binding enzyme complementation assays |
08/25/1993 | CA2090278A1 Prostaglandin e receptors, their dna and production |
08/24/1993 | US5239060 Muscular dystrophy protein, dystrophin |
08/24/1993 | US5238836 Genetic engineering; isolated DNA sequences |
08/24/1993 | CA1321563C Light inducible promoter |
08/19/1993 | WO1993016193A1 Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same |
08/19/1993 | WO1993016192A1 Humanised antibody against hepatitis |
08/19/1993 | WO1993016190A1 Bacterial macromolecule extract, method for preparing same and pharmaceutical composition containing said extract |
08/19/1993 | WO1993016185A2 Biosynthetic binding protein for cancer marker |
08/19/1993 | WO1993016184A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
08/19/1993 | WO1993016179A1 MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING |
08/19/1993 | WO1993016107A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes |
08/19/1993 | WO1993016099A2 Dna sequences encoding novel growth/differentiation factors |
08/19/1993 | WO1993016096A1 Recombinant gibberellin dna and uses thereof |
08/19/1993 | WO1993015762A1 Feline infectious peritonitis vaccine and method of preparation |
08/19/1993 | WO1993015755A1 Protease-resistant thrombomodulin analogs |
08/19/1993 | WO1993015608A1 Prevention of retinal injury and degeneration by specific factors |
08/19/1993 | CA2372813A1 Biosynthetic binding protein for cancer marker |
08/19/1993 | CA2129533A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes |
08/19/1993 | CA2129517A1 Recombinant gibberellin dna and uses thereof |
08/19/1993 | CA2129445A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
08/19/1993 | CA2129370A1 Protease-resistant thrombomodulin analogs |
08/19/1993 | CA2128698A1 Feline infectious peritonitis vaccine and method of preparation |
08/19/1993 | CA2106854A1 Extract of bacterial macromolecules, a process for its preparation and a pharmaceutical composition containing the same |
08/19/1993 | CA2089541A1 Selective removal of n-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1 |
08/18/1993 | EP0556152A1 Pyridinium derivatives and their use in determining connective tissue disorders in humans and animals |
08/18/1993 | EP0556111A1 Hybrid protein complexes, their process of preparation, and their applications as an agent in diagnostic and in the therapeutic field or as a reagent relevant in medical approaches |
08/18/1993 | EP0556106A2 Antibody binding to human aldose reductase and its uses |
08/18/1993 | EP0555989A1 TGF-beta induced gene and protein |
08/18/1993 | EP0555880A2 The CD40CR receptor and ligands therefor |
08/18/1993 | EP0555785A1 Smooth muscle mitogen and DNA coding therefor |
08/18/1993 | EP0555454A1 Cell culture process and medium for the growth of adherent animal cells |
08/18/1993 | EP0555435A1 DNA SEQUENCE ENCODING BOVINE $g(a)-LACTALBUMIN AND METHODS OF USE |
08/18/1993 | EP0555425A1 Antibodies to streptolysin o derivatives and variants |
08/18/1993 | EP0555405A1 Specific detection of antibodies to human t-cell leukemia viruses |
08/18/1993 | EP0555397A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
08/18/1993 | EP0555370A1 Methods and applications for efficient genetic suppressor elements |
08/18/1993 | EP0555363A1 Identification of a suppressor of atherogenic apolipoprotein |
08/18/1993 | EP0555286A1 Cell growth inhibitors |
08/18/1993 | EP0555205A1 Dna encoding a growth factor specific for epithelial cells |
08/18/1993 | EP0542897A4 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors |
08/18/1993 | EP0425482B1 Human insulin analogs and preparations containing them |
08/18/1993 | CA2067837A1 Process for producing economic protein by using silkworms |
08/17/1993 | US5236844 Dna sequences |
08/17/1993 | US5236836 Catalyst for the hydrolysis of peptide bond in vasoactive intestinal peptide |
08/17/1993 | US5236829 Method of producing monokine induced by gamma interferon |
08/17/1993 | US5236825 Complexing |
08/16/1993 | EP0652951A4 Gdf-1. |
08/12/1993 | CA2089139A1 Complex hybrid proteins, method for preparing them, their applications as diagnostic agent, as agent intended for therapeutic use |
08/11/1993 | EP0554670A2 Specific antibodies against activated platelets, their production and applications in diagnostics and therapeutics |